We analyzed blood plasma from 41 newly diagnosed treatment-naïve ET patients and 43 controls, for levels of CRP, endostatin, GDF15, MMP9, PTX3, E-selectin, P-selectin, sVEGFR1 and sVEGFR2. The gene discussed is SELE; the disease is essential thrombocythemia.